Cargando…
Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease
BACKGROUND: The aim of this study was to investigate the association of visit-to-visit variability of hemoglobin A1c (HbA1c) and glycated albumin (GA) with the risk of lower extremity atherosclerotic disease (LEAD). METHOD: We performed a prospective cohort study of 436 patients with type 2 diabetes...
Autores principales: | Shen, Yun, Dai, Dongjun, Lu, Jingyi, Wang, Yufei, Zhu, Wei, Bao, Yuqian, Hu, Gang, Zhou, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731472/ https://www.ncbi.nlm.nih.gov/pubmed/33302958 http://dx.doi.org/10.1186/s12933-020-01187-1 |
Ejemplares similares
-
Association of Advanced Glycation End Products With Lower-Extremity Atherosclerotic Disease in Type 2 Diabetes Mellitus
por: Ying, Lingwen, et al.
Publicado: (2021) -
The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes
por: He, Xingxing, et al.
Publicado: (2020) -
Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c
por: Ma, Xiaojing, et al.
Publicado: (2015) -
Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients
por: Zhang, Xiaoyan, et al.
Publicado: (2015) -
Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohort
por: Slieker, Roderick C., et al.
Publicado: (2019)